Allweiss L. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. PS-162.
Hepatitis delta genotype 5 geassocieerd met betere prognose dan genotype 1
mrt 2020 | Hepatitis, Virale infecties